medigraphic.com
ISSN 1405-1699 (Impreso)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2000, Número 1

<< Anterior

Alerg Asma Inmunol Pediatr 2000; 9 (1)


Enfermedad de Behçet

Alvarado N, Ambriz MJ

Idioma: Español
Referencias bibliográficas: 33
Paginas: 32-39
Archivo PDF: 376.72 Kb.


RESUMEN

La enfermedad de Behçet es una enfermedad inflamatoria de causa desconocida caracterizada por úlceras orales, aftosas recurrentes, úlceras genitales, uveítis y lesiones cutáneas. Todas las manifestaciones son autolimitadas excepto la afección ocular. Los ataques repetitivos de uveítis pueden causar cegueras. La enfermedad de Behçet es una enfermedad inflamatoria persistente. La afección del tracto gastrointestinal, sistema nervioso central y grandes vasos es menos frecuente, aún así pueden amenazar la vida del paciente. La susceptibilidad de la enfermedad de Behçet está fuertemente asociada con la presencia del alelo HILA-B51. Algunos factores ambientales como agentes infecciosos también han sido implicados en la patogénesis de esta enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ozen S. Vasculopathy, Behçet’s syndrome, and familial mediterrean Fever. Curr Opin Rheumatol 1999; 11: 393-8.

  2. Bhakta BB, Silman AJ. Behçet’s Disease: evaluation of a new instrument to measure clinical activity. Rheumatology 1999; 38: 728-33.

  3. Balabanove M, Calamia KT, Perniciaro C, O’Duffy JD. A study of the cutaneous manifestations of Behcet’s disease in patients from the United States. J Am Acad Dermatol 1999; 41: 540-5.

  4. Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behçet’s disease. Jpn J Ophthalmol 1999; 43: 312-7.

  5. Lee KH, Bang D, Choi ES, Chun WH, Lee ES, Lee S. Presence of circulating antibodies to a disease-specific antigen on cultures human dermal microvascular endothelial cells in patients with Behçet’s disease. Arch Dermatol Res 1999; 292: 374-81.

  6. Calzada-Sierra DJ, García-Fidalgo J, Mustelier-Becquer R, Fernández-Domínguez A, Hernández-González E. Neurological Behçet syndrome. Presentation of three cases. Rev Neurol 1999; 16-30(28): 1166-9.

  7. Keser G, Oksel F, Ozgen G, Aksu K, Doganavsargil E. Serum prolactin levels in Behçet’s Syndrome. Clin Rheumatol 1999; 18: 351-2.

  8. Tanaka T, Yamakawa N, Koike N, Suzuki J, Mizuno F. Usui M. Behçet’s disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm 1999; 7: 69-74.

  9. Conti F, Priori R, Pittoni V, Pivetti-Pezzi P, Valesini G. Antiphospholipid antibodies and trombosis. Lancet 1999; 354: 73.

  10. Tohme A, El-Khoury I, Ghayad E. Behçet Disease. Genetic factors, immunologic aspects and new therapeutic methods. Presse Med 1999; 28: 1080-4.

  11. Orem A, Cimsit G, Deger O, Vanizor B, Karahan SC. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet’s disease. Dermatology 1999; 198: 243-6.

  12. Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina. Enhancement of endothelial cell E-selection expression by sera from patients with active Behçet’s disease moderate correlation with antiendothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 1999; 91: 330-7.

  13. Duruzoy C, Alpsoy E, Yilmaz E. Pityriasis rosea in a patient with Behçet’s disease treated with interferon µ-2A. J Dermatol 1999; 26: 225-8.

  14. Alpsoy E, Er H, Duruzoy C, Yilmaz E. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study. Arch Dermatol 1999; 135: 529-32.

  15. Yamasaki S, Koyano T. A case of pediatric Behçet’s disease with intestinal involvement. J Dermatol 1999; 26: 160-3.

  16. Matsui T, Kurokawa M, Kobata T, Oki S, Azuma M, Tohma S, Inoue T, Yamamoto K, Nishioka K, Kato T. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol 1999; 162: 4328-35.

  17. Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 1999; 106: 586-9.

  18. Hashimoto T. Behçet Disease. Nippon Rinsho 1999; 57: 374-7.

  19. Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoc M. Decreased nitric oxide production in patients with Behçet’s disease. Dermatology 1999; 198: 33-6.

  20. Demirogly H, Yalcin S, Buyukasik Y, Ozcebe OI, Dundar S. Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behçet’s disease: a prospective study. Ann Rheum Dis 1998; 57: 694-6.

  21. Yasici H, Yurdakul S, Hamuryudan V. Behçet’s Syndrome. Curr Opin Rheumatol 1999 11: 53-7.

  22. Cantini F, Salvarani C, Niccoli L, Senesi C, Truglia MC, Padula A, Olivieri I. Behçet’s disease with unusual cutaneous lesions. J Rheumatol 1998; 25: 2469-72.

  23. O’Duffy JD, Calamia K, Cohen S, Goronzy JJ, Herman D, Jorizzo J, Weyand G, Matteson E. Interpheron alpha treatment of Behçet’s disease. J Rheumatol 1998; 25: 1938-44.

  24. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 48-59.

  25. Kotter I, Eckstein AK, Stubiger N, Zierhut M. Treatment of ocular symptoms of Behçet’s disease with interpheron alpha 2A: a pilot study. Br J Ophthalmol 1998; 83: 488-94.

  26. Krause I, Uziel Y, Guedj D, Mukamel M, Molad Y, Amit M, Weinberger A. Mode of presentation and multisystem involvement in Behçet’s disease: the influence of sex and age of disease onset. J Rheumatol 1998; 25: 1566-9.

  27. Verity DH, Wallace GR, Seed PT, Kanawati CA, Ayesh I, Holand-Gladwish J, Stanford MR. Soluble adhesion molecules in Behçet’s disease. Ocul Immunol Inflamm 1998; 6: 81-92.

  28. Moore PM. Central Nervous System vasculitis. Cur Opin Neurol 1998; 11: 241-6.

  29. Serdaroglu P. Behçet’s disease and the nervous system. J Neurol 1998; 245: 197-205.

  30. Kone-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, Bernard JL. Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. J Pediatr 1998; 132: 721-5.

  31. Sullu Y, Oge I, Erkan D, Ariturk N, Mohajeri F. Cyclosporin A therapy in severe uveitis of Behçet’s disease. Acta Ophthalmol Scand 1998; 76: 96-9.

  32. Fresko I, Soy M, Hamurydan V, Yurdakul S, Yavuz S, Tumer Z, Yazici H. Genetic participation in Behçet’s syndrome. Ann Rheum Dis 1998; 57: 45-8.

  33. Kaklami VG, Vaiopoulos G, Kaklamanis PG. Behçet’s Disease. Semin Arthritis Rheum 1998; 27: 197-217.




2020     |     www.medigraphic.com